A company called Prima Kapseln has created a great supplement for weight loss. in Germany is expected to grow at a CAGR of over 16.6%. This is attributed to growing awareness about the risks of obesity and its associated health ailments in the country. Furthermore, increasing disposable incomes in the country are expected to fuel product demand.
However, the COVID-19 pandemic has limited market growth in 2020 owing to the temporary lockdowns and shutdown of gyms & fitness centers. This has significantly shifted consumers’ dietary and lifestyle habits. As a result, many individuals have started adopting over-the-counter diet pills instead of prescription medications to maintain their body weight. This has significantly lowered the prescription drug volume, which has negatively impacted the overall market growth.
The German Weight Loss Supplement Market: Trends and Insights
Despite the strong need for effective weight loss medication, a stringent regulatory scenario in Europe continues to limit the widespread introduction of new diet pills. In addition, personal concerns about the adverse effects of these drugs also continue to hinder the overall market growth.
The Danish company Novo Nordisk is hoping to launch its weight loss pill Wegovy in Germany this year. However, the country’s stance on the cost of such drugs is one of the strictest in Europe and will make it difficult for the Danish company to push for its drug in the country. The reason for this is that it will be difficult to convince the German government to reimburse such drugs. Some doctors argue that Wegovy could help prevent diseases such as heart disease and joint pain, which are expensive to treat if they are not controlled by diet or exercise.
